Drug
Taxoprexin
Taxoprexin is a pharmaceutical drug with 5 clinical trials. Historical success rate of 60.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
60.0%
Based on 3 completed trials
Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
2(40%)
Phase Distribution
Ph phase_3
2
40%
Ph phase_2
3
60%
Phase Distribution
0
Early Stage
3
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
Phase 3Large-scale testing
2(40.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
60.0%
3 of 5 finished
Non-Completion Rate
40.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(2)
Detailed Status
Completed3
Terminated2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
60.0%
Most Advanced
Phase 3
Trials by Phase
Phase 23 (60.0%)
Phase 32 (40.0%)
Trials by Status
completed360%
terminated240%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Taxoprexin® Treatment for Advanced Eye Melanoma
NCT00244816
terminatedphase_2
Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract
NCT00422877
completedphase_2
Taxoprexin Treatment for Advanced Skin Melanoma
NCT00249262
completedphase_3
Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer
NCT00243867
terminatedphase_3
Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma
NCT00087776
Clinical Trials (5)
Showing 5 of 5 trials
NCT00244816Phase 2
Taxoprexin® Treatment for Advanced Eye Melanoma
NCT00422877Phase 2
Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract
NCT00249262Phase 2
Taxoprexin Treatment for Advanced Skin Melanoma
NCT00243867Phase 3
Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer
NCT00087776Phase 3
Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5